Search
Mitiglinide
go.drugbank.com/drugs/DB01252InvestigationalMitiglinide is a drug for the treatment of type 2 diabetes. It may stimulate insulin secretion in beta-cells by closing off ATP dependant potassium ion channels.
St. John's Wort
go.drugbank.com/drugs/DB01323ApprovedNutraceuticalCategories: P-glycoprotein inducers, Cytochrome P-450 SubstratesCeftibuten
go.drugbank.com/drugs/DB01415ApprovedInvestigationalCeftibuten is a third-generation cephalosporin antibiotic that is orally-administered.
Aprindine
go.drugbank.com/drugs/DB01429ExperimentalAprindine is a cardiac depressant used in arrhythmias.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 SubstratesBezitramide
go.drugbank.com/drugs/DB01459ApprovedIllicitWithdrawnBezitramide has never been FDA approved and is currently a schedule II drug. … Bezitramide is a narcotic analgesic which was discovered in 1961, clinically tested around the 1970's [A14383], and marketed under the name Burgodin.
Fenethylline
go.drugbank.com/drugs/DB01482ExperimentalCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 SubstratesDesomorphine
go.drugbank.com/drugs/DB01531ExperimentalIllicitCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2B6 SubstratesMethylenedioxyethamphetamine
go.drugbank.com/drugs/DB01566ExperimentalIllicitCategories: P-glycoprotein inhibitors, Cytochrome P-450 SubstratesCinolazepam
go.drugbank.com/drugs/DB01594InvestigationalCinolazepam is a benzodiazepine derivative with anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant activity. It is not approved in Canada or America.
Pargyline
go.drugbank.com/drugs/DB01626ApprovedPargyline is a monoamine oxidase inhibitor with antihypertensive properties.
Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates